Wealth Advisors Of Iowa, LLC Purple Biotech Ltd. Transaction History

Wealth Advisors Of Iowa, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$0.78 - $1.67 $780 - $1,670	1,000 Added 7.54%	14,270 $11,000
Q2 2023 Jul 25, 2023	BUY	$1.38 - $2.05 $1,055 - $1,568	765 Added 6.12%	13,270 $18,000
Q4 2022 Feb 10, 2023	BUY	$1.38 - $2.22 $1,655 - $2,664	1,200 Added 10.61%	12,505 $17,000
Q3 2022 Nov 15, 2022	BUY	$1.9 - $2.69 $21,479 - $30,410	11,305 New	11,305 $23,000

19.3K

Ticker PPBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,303,300
Market Cap $46.5M
Description
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...

Get notified when there are updates to the investment portfolio of Wealth Advisors Of Iowa, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Advisors Of Iowa, LLC with notifications on news.